Circadian Mechanisms in Progression of Obstructive Apnea in Humans

人类阻塞性呼吸暂停进展的昼夜节律机制

基本信息

  • 批准号:
    7589472
  • 负责人:
  • 金额:
    $ 22.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Obstructive sleep apnea-hypopnea syndrome (SAHS) is a debilitating condition affecting 2-4% of adults. Others and we have found that apnea usually worsens across a single night even when in the same sleep stage and lying posture. Our recent data show large endogenous circadian clock related changes in numerous variables that could affect apnea severity including ventilatory chemosensitivity (hypercapnic ventilatory response), pulmonary function, and physiological responses to arousal from sleep. The circadian pacemaker as well as sleep itself can affect some of these variables, and these effects have never before been experimentally separated. Thus, the aims of this study are to perform the first assessment of the contribution of endogenous circadian factors in the genesis and/or progression of obstructed breathing during sleep in patients with SAHS. To achieve this aim, breathing abnormalities will be examined when subjects with SAHS sleep at varied phases of the circadian cycle throughout a 10 day 'forced desynchrony' protocol. If the circadian system is responsible for increases in apnea severity across the night, this may reveal novel mechanisms causing modulation of apnea severity. Among the likely factors that will be examined are circadian alterations in respiratory arousal thresholds and/or ventilatory chemosensitivity. On the other hand, if apnea still worsens across the sleep period when sleep occurs during the day, this would suggest that the circadian system is not responsible for the worsening of apnea across the night. In this case other hypotheses would emerge, such as the possibility that apneas at the beginning of the night affect subsequent apneas (e.g., via anatomical or physiological maladaptations, which could be explored in subsequent experiments). This study ought to aid our understanding of the natural history and underlying pathophysiological mechanisms of SAHS. PUBLIC HEALTH RELEVANCE: Obstructive sleep apnea-hypopnea syndrome is a debilitating condition affecting 2-4% of adults. The aims of this study are to assess the contribution of endogenous circadian factors in the genesis and/or progression of obstructed breathing during sleep. This study ought to aid our understanding of the natural history and underlying pathophysiological mechanisms of SAHS.
描述(由申请人提供):阻塞性睡眠呼吸暂停低通气综合征(SAHS)是一种影响2-4%成年人的衰弱性疾病。其他人和我们发现,呼吸暂停通常持续一个晚上,即使在相同的睡眠阶段和躺姿。我们最近的数据显示,大量内源性生物钟相关的变化,可能会影响呼吸暂停的严重程度,包括呼吸暂停的化学敏感性(高碳酸血症的呼吸反应),肺功能和生理反应,从睡眠中觉醒。昼夜节律起搏器和睡眠本身可以影响其中一些变量,这些影响以前从未被实验分离。因此,本研究的目的是进行第一次评估的内源性昼夜因素的发生和/或睡眠期间的呼吸阻塞的进展SAHS患者的贡献。为了实现这一目标,在10天的“强迫睡眠”方案中,当SAHS受试者在昼夜节律周期的不同阶段睡眠时,将检查呼吸异常。如果昼夜节律系统是导致夜间呼吸暂停严重程度增加的原因,这可能揭示了导致呼吸暂停严重程度调节的新机制。其中可能的因素,将被检查的是昼夜节律改变呼吸唤醒阈值和/或化疗敏感性。另一方面,如果在白天发生睡眠时,呼吸暂停仍然在整个睡眠期间持续,这表明昼夜节律系统不是夜间呼吸暂停恶化的原因。在这种情况下,会出现其他假设,例如夜间开始时的呼吸暂停影响随后的呼吸暂停的可能性(例如,通过解剖学或生理学上的适应不良,这可以在随后的实验中探索)。这项研究应该帮助我们理解SAHS的自然史和潜在的病理生理机制。公共卫生相关性:阻塞性睡眠呼吸暂停低通气综合征是一种影响2-4%成年人的衰弱性疾病。本研究的目的是评估内源性昼夜因素在睡眠呼吸阻塞的发生和/或进展中的作用。这项研究应该帮助我们理解SAHS的自然史和潜在的病理生理机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN A SHEA其他文献

STEVEN A SHEA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN A SHEA', 18)}}的其他基金

Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
  • 批准号:
    10438560
  • 财政年份:
    2021
  • 资助金额:
    $ 22.17万
  • 项目类别:
Endogenous circadian mechanisms underlying cardiovascular risk
心血管风险的内源性昼夜节律机制
  • 批准号:
    10656183
  • 财政年份:
    2021
  • 资助金额:
    $ 22.17万
  • 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
  • 批准号:
    9921998
  • 财政年份:
    2018
  • 资助金额:
    $ 22.17万
  • 项目类别:
Sleep and Circadian Mechanisms Contributing to Disparity in Prevalence of Hypertension Between Black and White Americans
睡眠和昼夜节律机制导致美国黑人和白人之间高血压患病率的差异
  • 批准号:
    9921461
  • 财政年份:
    2018
  • 资助金额:
    $ 22.17万
  • 项目类别:
Circadian rhythms and cardiovascular risk
昼夜节律和心血管风险
  • 批准号:
    9252505
  • 财政年份:
    2015
  • 资助金额:
    $ 22.17万
  • 项目类别:
Circadian rhythms and cardiovascular risk
昼夜节律和心血管风险
  • 批准号:
    9109679
  • 财政年份:
    2015
  • 资助金额:
    $ 22.17万
  • 项目类别:
Circadian rhythms and cardiovascular risk
昼夜节律和心血管风险
  • 批准号:
    8965062
  • 财政年份:
    2015
  • 资助金额:
    $ 22.17万
  • 项目类别:
Circadian Mechanisms in Progression of Obstructive Apnea in Humans
人类阻塞性呼吸暂停进展的昼夜节律机制
  • 批准号:
    7841754
  • 财政年份:
    2009
  • 资助金额:
    $ 22.17万
  • 项目类别:
Chronobiology of cardiovascular and pulmonary disease
心血管和肺部疾病的时间生物学
  • 批准号:
    6909786
  • 财政年份:
    2004
  • 资助金额:
    $ 22.17万
  • 项目类别:
Circadian and behavioral factors of cardiovascular risk
心血管风险的昼夜节律和行为因素
  • 批准号:
    7114283
  • 财政年份:
    2004
  • 资助金额:
    $ 22.17万
  • 项目类别:

相似海外基金

Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
  • 批准号:
    2885806
  • 财政年份:
    2023
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
  • 批准号:
    10772386
  • 财政年份:
    2023
  • 资助金额:
    $ 22.17万
  • 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    474619
  • 财政年份:
    2022
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
  • 批准号:
    485965
  • 财政年份:
    2022
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
  • 批准号:
    466358
  • 财政年份:
    2022
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
  • 批准号:
    402040
  • 财政年份:
    2019
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
  • 批准号:
    18K16103
  • 财政年份:
    2018
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
  • 批准号:
    377313
  • 财政年份:
    2017
  • 资助金额:
    $ 22.17万
  • 项目类别:
    Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
  • 批准号:
    9315111
  • 财政年份:
    2016
  • 资助金额:
    $ 22.17万
  • 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
  • 批准号:
    8734273
  • 财政年份:
    2013
  • 资助金额:
    $ 22.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了